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A B ST R AC T 
 
 
Introduction. The impact of inflammatory bowel diseases (IBD) on the quality 
of life (QoL) of patients is significant and it has important social and professional 
consequences. Materials and methods. We aimed to describe the patients’ 
perspective regarding the impact of IBD on their overall QoL and to evaluate the 
differences between men and women. An observational cross-sectional study, 
that included 180 patients with IBD in clinical remission, was conducted. All the 
patients completed a number of 3 questionnaires in order to evaluate the general 
aspects of their QoL. A separate questionnaire was created regarding gender-
specific issues in women with IBD encounter. Also, particular features such as 
the incidence of anemia and osteoporosis among IBD patients were documented. 
The data obtained were analyzed and compared between the two gender-
classified groups. Results. According to the Short Inflammatory Bowel Disease 
Questionnaire (SIBDQ), patients had a general perception of a good QoL, but 
the impact was higher in women. Fatigue and tiredness were severely perceived 
almost to the same degree regardless of their gender, whereas anxiety and 
unemployment were more present in men. No significant differences in women 
with IBD during the active disease and during disease remission were found. 
Conclusions. The overall quality of life of IBD patients is affected in many 
aspects, leading to the deterioration of their social and professional lives, for both 
men and women, but some aspects remain gender-specific and require a 
personalized standard of care.   
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Inflammatory bowel diseases (IBD) have a great 
impact on the quality of life (QoL), in both men and 
women, and represent a substantial burden on the patient 
and the caregivers. The consequences can be observed in 
the increased rates of depression, anxiety, chronic fatigue 
and reduced workforce participation seen in patients with 
Crohn’s disease or ulcerative colitis [1, 2]. 
The impact of IBD on the QoL is multifaceted, from 
direct physical distress because of symptoms, in addition 
to psychological impairment, financial burden and low 
work productivity [1]. People with IBD frequently require 
multidisciplinary care, including mental health care, that 
can help in the development of adaptive coping 
mechanisms in order to reduce psychological distress. 
Several studies have demonstrated that the QoL is 
impaired in these patients in comparison with the general 
population [3,4], but only a few evaluated the differences 
between men and women. As women are regarded as being 
more sensitive to social stigma of having a chronic disease 
and being prone to anxiety and depression [5], we tend to 
think that women with IBD should be more affected than 
men, but are they really so? 
In order to answer this question, we aimed to make a 
comparison between women and men regarding the impact 
of IBD on their overall QoL. We tried to raise physicians’ 
awareness on the gender-specific aspects women with IBD 
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may have and the impact on their self-esteem, resilience 
and overall coping mechanisms on the daily basis. 
Materials and Methods 
We conducted an observational cross-sectional study, 
that included patients with IBD who attended our 
Gastroenterology and Interventional Endoscopy 
Department from January 2017 until January 2020. 
Patients previously diagnosed with IBD, either 
ulcerative colitis or Crohn’s disease, who achieved clinical 
remission under treatment with biologic agents, were 
included. Patients’ consent for data registration and 
subsequent use in clinical research was obtained at the time 
of inclusion in the current study, after the approval of the 
local ethics committee was obtained. Each patient received 
a number of questionnaires regarding their perception on 
the overall QoL, using the Short Inflammatory Bowel 
Disease Questionnaire (SIBDQ) [6], the degree of chronic 
fatigue using the Functional Assessment of Chronic Illness 
Therapy-Fatigue Scale (FACIT-F) [7], the level of anxiety 
and depression caused by numerous hospital admissions 
(HADS) [8] and the impact of the disease on work 
productivity. Furthermore, a particular questionnaire was 
created for women with IBD specifically, concerning 
issues such as menstruation (age of menarche, variations of 
menstruation symptoms during remission and active 
disease) and the possibility of obtaining a full-term 
pregnancy with or without continuing the biologic 
treatment, the Special Issues of Women with IBD 
Questionnaire (SIWIBDQ) (Table 1). 
Nevertheless, the incidence of osteoporosis and anemia 
among our patients was also documented from the data 
provided by the periodical biological examinations and 
bone density scans of each patient. 
A total of 180 adult patients achieved sustained clinical 
and biochemical remission under biologic treatment. The 
data regarding the symptoms and patient-reported 
outcomes were gathered using the previously stated 
questionnaires, after a minimum of 6 months of persistent 
clinical remission. Clinical remission was defined as the 
absence of symptoms: resolution of diarrhea and bleeding, 
abdominal pain and weight loss. However, laboratory 
testing was performed for each patient in order to correlate 
clinical with biochemical remission. Laboratory tests 
included complete blood count, inflammatory markers (C-
reactive protein), albumin level and fecal calprotectin 
levels. All patients included in this study had no 
leukocytosis on complete blood count tests and C-reactive 
protein and albumin levels were within normal range. Also, 
fecal calprotectin levels were normal. 
The exclusion criteria for participation in this study 
were pre-existing diagnoses of depression or anxiety 
disorder and continuous or intermittent treatment with anti-
depressant or anti-anxiety medications. 
 
Table 1. Special issues of women with IBD 
Questionnaire (SIWIBDQ) 
1. What was your menarche age? Points 
• 12-13 years 0 
• < 12 years 1 
• ≥ 14 years 2 
2. How do you perceive menstruation 
symptoms during clinical remission of IBD 
versus active disease phase? 
 
• Menstruation symptoms are less severe 0 
• Menstruation symptoms are the same 1 
• Menstruation symptoms are more severe 2 
3. Did you have any pregnancy since the 
biological treatment for IBD was initiated? 
 
• No 0 
• Yes 1 
4. If the answer to question 3 was yes, did you 
discontinue the biological treatment during 
pregnancy? 
 
• No 0 
• Yes 1 
Tick the box beside the reply that best describes 
your current situation. Please answer all the 
questions. 
Scoring:  
Total score: ______ 
     Normal = 0-3; Abnormal (case) = 4-6. 
From a total of 180 patients who met the inclusion 
criteria, 65 were women and 115 were men, with an 
average age of 37 years. Therefore, two groups were 
created based on the gender classification. 
All patients included in this study completed the 
following questionnaires: (1) Short Inflammatory Bowel 
Disease Questionnaire (SIBDQ); (2) Functional 
Assessment of Chronic Illness Therapy-Fatigue (FACIT-
F) and (3) Hospital Anxiety and Depression Scale (HADS). 
Women also completed the (4) Special issues of women 
with IBD Questionnaire (SIWIBDQ). 
The SIBDQ is a disease-specific health-related quality 
of life (HRQoL) measuring tool, meant to evaluate four 
domains – bowel, emotion, social and daily activities, and 
general well-being. Its importance lies in the capacity to 
address key points in one’s life, such as social life, 
psychological well-being, the degree of fatigue, the 
presence of depression and body image. The questionnaire 
contains 10 items, and each item has a 7-point scale from 
1 to 7. The absolute SIBDQ score ranges from 10 to 70, 
with higher values suggesting a better QoL. 
The Functional Assessment of Chronic Illness Therapy 
- fatigue (FACIT-fatigue) scale is an instrument designed 
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to assess fatigue and tiredness and their impact on daily 
activities and functioning in patients with chronic 
diseases. This score contains 13 items, each item being 
ranked from 0 to 4 points, with a total score of 52 points. 
The instrument includes aspects such as tiredness, 
weakness, lack of energy, listlessness and the impact of 
these feelings on daily activities (for example sleeping 
and social activities). A score under 30 points is 
representative for severe fatigue and the higher the score, 
the better the QoL of patients. 
In assessing the QoL of patients included in this study, 
a questionnaire consisting of a 7-question anxiety 
assessment and 7-question depression assessment, the 
HADS score, was also used. The score for each item ranges 
from zero to three, with three indicating the highest anxiety 
or depression level. A total subscale score of more than 11 
points out of 21 possible points suggests considerable 
symptoms of depression or anxiety, between 8 and 10 
being borderline abnormal, and less than 7 being normal. 
In order to fully understand the women-specific issues, 
we created the Special Issues of Women with IBD 
Questionnaire (SIWIBDQ), consisting of 4 questions 
regarding the menarche age, menstruation symptoms 
assessment during clinical remission in comparison with 
active disease phase and pregnancy (Table 1). 
All the data obtained were analyzed and compared 
between the two gender-classified groups. 
Results 
A total of 180 patients were included in this study. 
From these, 115 patients were men and 65 women, aged 
between 19-47 years, thus balancing the scale towards 
men, with a percentage of 63.89%. The majority of the 
patients had no other comorbidities (91.67%). Overall, 
median SIBDQ, FACIT-F, HADS-anxiety and HADS-
depression for males were 53.52, 17.04, 5.21, and 4.56, 
respectively, and for women, 52.30, 18.53, 4.69, and 4.07. 
the demographic data including patients’ clinical 
characteristics are shown in Table 2. 
The SIBDQ score 
A very useful tool in measuring health-related QoL is 
the Short Inflammatory Bowel Disease Questionnaire 
(SIBDQ). When asked to fill in the SIBDQ questionnaire, 
women included in this study (36.11% from the total of 
patients) obtained total scores ranging from 38 and 67 
points, with a median score of 52.30 points. Most of the 
patients were men (63.89%) and similar results were 
observed in this subgroup: their scores varied from 27 to 
68 points and the median score was 53.52 points. High 
median scores were identified in both subgroups, which 
means that the patients had a general perception of good 
QoL, but the impact was higher in women who obtained 
lower scores than men. 
The FACIT-F score 
The impact of the disease on the perception of fatigue 
was evaluated for the 115 male subjects in the study: the 
scores in this category of patients varied from 7 to 42, with 
a median score of 17.04 points. Women who completed this 
questionnaire and graded their symptoms obtained scores 
from 9 to 33 points, the median score among them being 
18.53 points. Therefore, fatigue and tiredness were severely 
perceived by the two groups almost to the same degree. 
The HADS score 
The HADS score can be divided into two subgroups 
HADS-anxiety and HADS- depression. The majority of the 
patients in our study were within the normal range, without 
significant differences between men and women for both the 
HADS-anxiety (78.26% vs. 76.92%) and HADS-depression 
(78.26% vs. 84.61%). In the borderline category, we 
encountered more women than men (15.38% vs. 4.34%) in 
the HADS-anxiety subgroup, whereas in the HADS-
depression subgroup there where only men (17.40%). In the 
abnormal category there were only 5 patients for the HADS-
anxiety and 3 patients for HADS-depression. But here, in 
comparison, the gender scale is inverted, as more men than 
women felt severe anxiety (17.4% men, 7.70% women) 
(Table 3) and more women than men felt severe depression 
(15.39% vs. 4.34%) (Table 4).  
Table 2. Demographic and clinical characteristics of 
patients with IBD. 
Variables N = 36 
Median age, years 42 (19-47) 
Males, n (%) 115 (63.89%) 
Females, n (%) 65 (36.11%) 
Other comorbidities, n (%)  
Diabetes mellitus 5 (2.78%) 
Arterial hypertension 10 (5.55%) 
None 165 (91.67%) 
Unemployment  
Males, n (%) 40 (22.23%) 
Females, n (%) 25 (13.89%) 
Anemia  
Present, n (%) 15 (8.33%) 
Absent, n (%) 165 (91.67%) 
Osteoporosis  
Males, n (%) 0 (0%) 
Females, n (%)  (8.33%) 
Median SIBDQ  
Males 53.52 
Females 52.30 
Median FACIT-F  
Males 17.04 
Females 18.53 
Median HADS-anxiety  
Males 5.21 
Females 4.69 
Median HADS-depression  
Males 4.56 
Females 4.07 
Median SIWIBDQ 1.85 
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Table 3. HADS - anxiety score. 
 Women percentage 
(number of cases) 
Men percentage  
(number of cases) 
Normal 76.92% (50) 78.26% (90) 
Borderline 
abnormal 
15.38% (10) 4.34% (5) 
Abnormal 7.70% (5) 17.4% (20) 
Total 100% (65) 100% (115) 
 
Table 4. HADS - depression score. 
 Women percentage  
(number of cases) 
Men percentage  
(number of cases) 
Normal 84.61% (55) 78.26% (90) 
Borderline 
abnormal 
0% (0) 17.40% (20) 
Abnormal 15.39% (10) 4.34% (5) 
Total 100% (65) 100% (115) 
 
Table 5. Menarche and the evaluation of dysmenorrhea 
during the active disease 
Age of menarche 
Number of patients 
(percentage) 
11 years 15  (23.07%) 
12 years 25  (38.48%) 
13 years 15  (23.07%) 
14 years 10  (15.38%) 
Dysmenorrhea during the 
active stage of the disease 
 
More painful 5  (7.69%) 
Equally painful 55  (84.62%) 
Less painful 5  (7.69%) 
Pregnancy  
No pregnancies 50 (77%) 
At least one pregnancy 15 (33%) 
Continued biological 
treatment during pregnancy 
10 (66.60%) 
Discontinued biological 
treatment during pregnancy 
5 (33.40%) 
The impact on work activity and daily activities 
Regarding the employment status and work 
productivity of IBD patients, we observed that more than 
one third was unemployed, i.e., more men than women 
(22.23% vs. 13.89%). Regarding the work productivity and 
the number of hours missed from work due to bowel 
problems, the majority (56%) of the patients, all women, 
did not miss one single hour from work. Only men (8%) 
had missed a few hours from work because of bowel 
problems and general malaise.  
Special issues of women with IBD and the safety of 
biologic agents during pregnancy 
Regarding the specific issues of women with IBD such 
as menstruation, the mean age of menarche was between 
12 and 13 years (61.55%), the same as the one for the 
general population [9]. Moreover, we did not find 
significant differences in women with IBD between 
dysmenorrhea during the active disease and during disease 
remission, as 84.62% (55 patients) experienced equally 
painful periods (Table 5). 
Although 77% of the women did not have any 
pregnancy prior to the diagnosis, 23% were able to deliver 
a full-term baby without complications, out of which 
66.60% continued the biologic treatment during pregnancy 
and only 33.40% discontinued it. 
Anemia and osteoporosis among IBD patients 
The topic of anemia and osteoporosis in patients with 
IBD benefits from little attention when analyzing extra-
intestinal disease complications. In our study, we observed 
that 92% of our patients have no anemia, which shows that 
the disease is controlled and the patients respond well to 
iron treatment, and only 9% of the patients, all women, had 
osteoporosis. 
Discussions 
The results of this study focused on the psychological 
impact of IBD, demonstrating that although both men and 
women obtained high median scores according to the 
SIBDQ questionnaire, therefore having a general 
perception of an optimum QoL, the impact was higher for 
women, who obtained lower scores in comparison with 
men. 
A study published in 2020 reports similar results: a 
lower QoL among women, compared to men diagnosed 
with IBD [10]. These findings correspond to the data 
observed in the general population, more precisely a higher 
rate of absenteeism from work and a more frequent use of 
healthcare services among women compared to men [10, 
11]. Another important aspect that contributes to a reduced 
QoL is the presence of physical asthenia. Compared to 
men, women report a higher frequency and intensity of 
physical asthenia. This symptom is independent from the 
active state of the disease and the presence or absence of 
anemia, one of the causal factors [12-14]. 
However, a surprising feature pointed out by this study 
was that more than one third of the patients (36.1%) are 
unemployed, because of various reasons. Even though they 
are predominantly young adults, living with IBD is 
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definitely a challenge because work productivity and 
employment prospectors are diminished, both directly by 
the symptoms and the complications of the disease, and, 
indirectly, by the psychological distress patients have to 
cope with, making it difficult to get and, especially, to keep 
a workplace. 
A study conducted in Norway reports higher rates of 
unemployment and sick leave among patients diagnosed 
with IBD when compared to the general population [15]. 
Moreover, the unemployment rate was slightly higher in 
women compared to men (12.4% vs. 11.1%) [16]. The 
unemployment rate was higher in patients diagnosed with 
ulcerative colitis (13.2%) compared to those diagnosed 
with Crohn disease (8.7%) [15]. The mean unemployment 
age in patients with ulcerative colitis was 55.3 years, 
compared to 42.2 years in those with Crohn disease [15]. 
Even if fatigue and tiredness are more and more present 
among the general population due to a constant need to 
keep up with each other, especially in the working 
environment, it represents a daily burden for IBD patients, 
regardless of their gender [16]. According to the FACIT-F 
score, both women and men were severely affected, 
obtaining similar scores. 
Numerous studies show that the QoL is impaired in 
these patients in comparison with the general population. 
Also, psychological distress does not always correlate with 
the activity and severity of the disease, because even during 
the clinical remission, patients may experience the 
impairment of the QoL [1-4]. 
Disease chronicity requires the development of self-
management and coping skills over time; therefore, it is not 
surprising that IBD patients have an increased risk of 
mental health issues, including depression, which is an 
important problem that patients often experience; 
therefore, it is essential for the caregiver to recognize these 
diseases in the early stages. Recent studies show that the 
relationship between depression and chronic disease is 
bidirectional, with poor health leading to poor self-
management, as well as poor self-management leading to 
poor health [17,18]. 
The ongoing problem depression and anxiety pose in 
IBD patients is outlined by this study by using the HADS 
anxiety and depression questionnaire, which showed that 
anxiety is more present in men than women, whereas 
depression was encountered more predominantly in 
women. 
In addition to the huge impact that IBD has on the QoL, 
people living with IBD face other numerous challenges. 
These include social stigma of suffering from a chronic 
disease, affordability of medications, diminished 
employment prospects, difficulty with leisure time and 
travelling, limited community-based supports and 
inequitable access to health care specialists and services 
[16,18]. Reducing these difficulties should be a priority for 
physicians and health care providers, to improve the QoL 
of their patients. 
During flares, symptoms of IBD (both gastrointestinal 
and systemic symptoms) disrupt immediate activities and 
cause worry and embarrassment to patients. These 
immediate effects result in a plethora of impacts on the 
patient’s life and psychological well-being, which continue 
to have consequences even during the clinical remission of 
the disease, but to a lower degree [19]. 
A 2016 systematic review analyzed 171 studies 
including 158,371 individuals and showed a prevalence 
rate of anxiety of approximately 20% and a prevalence rate 
of depression of 15% in patients with IBD [20]. Both 
mental disorders had a higher prevalence during the disease 
activity period compared to the remission period. The 
estimated anxiety prevalence in patients with IBD during 
the disease activity was 75.6%, compared to 20.5% in the 
general population. It is noteworthy that the anxiety 
prevalence has been shown to be higher in patients with 
active IBD compared to patients with diabetes or chronic 
obstructive pulmonary disease [20-22]. The estimated 
depression prevalence in patients with active disease was 
40.7%, compared to 15.2% in the general population. 
Depressive disorders have also been diagnosed more 
frequently in patients with Crohn disease compared to 
those with ulcerative colitis [20]. 
Interestingly, we found that although both men and 
women obtained similar scores, men were more affected 
by anxiety, encountered more difficulties getting and, 
especially, keeping a workplace, which had a huge impact 
on their social life as well. 
A key strength of this study was the evaluation of 
special issues women with IBD have, despite the 
maintenance of remission under biologic agents. 
Moreover, by using accessible and easy to understand and 
answer questionnaires, we were able to obtain clinical data, 
as it is experienced by each patient. An important limitation 
of this study is the small number of patients included, but 
the data obtained can be a starting point for further larger 
prospective multi-center studies.  
Although women are more affected by depression and 
social stigma than men, they are more resilient and develop 
better coping mechanisms, therefore obtaining a better 
QoL than men.  
These results correspond to the existing data that 
highlight the development of better coping mechanisms in 
women, compared to men diagnosed with IBD [23,24]. 
The data so far support a greater negative impact on the 
QoL of women with IBD compared to men diagnosed with 
the same conditions [25-27]. 
Nevertheless, we must highlight that, even during the 
sustained clinical remission, these patients, regardless of 
their gender, experience QoL impairment. 
   




✓ Inflammatory bowel diseases (IBD) have a great 
impact on the quality of life (QoL). 
✓ The QoL of patients with IBD is affected in many 
aspects, leading to the deterioration of their social and 
professional lives, regardless of their gender, even if 
the majority of patients regarded themselves as having 
a good QoL.  
✓ The data show that there are differences between men 
and women. 
Conclusions 
Our study results show that the QoL of patients with 
IBD is affected in many aspects, leading to the 
deterioration of their social and professional lives, 
regardless of their gender, even if the majority of patients 
regarded themselves as having a good QoL. Moreover, the 
data show that there are differences between men and 
women; when asking the question if women are really 
more affected than men, we observed that, although 
women encounter more difficulties, they have an overall 
better QoL than men. Nevertheless, future longitudinal 
studies on the psychological impact of patients with IBD 
are required in order to help us better understand their 
gender-specific needs, create better measurement tools and 
improve their QoL.  
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